PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pediatrics, Division of Pediatric Infectious Diseases, New York University Grossman School of Medicine, New York, New York, USA.\', \'Department of Medicine, Division of Infectious Diseases and Immunology, New York University Grossman School of Medicine and NYU Langone Vaccine Center, New York, New York, USA.\', \'Department of Population Health, Division of Bioethics, New York University Grossman School of Medicine, New York, New York, USA.\', \'Department of Microbiology, New York University Grossman School of Medicine, New York, New York, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa656
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32459832
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Importance of Pediatric Inclusion in COVID-19 Therapeutic Trials.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all